QLOSI for Presbyopia
What QLOSI Is and How It Helps Near Vision
According to the FDA (NDA 217836, 2023), QLOSI (pilocarpine hydrochloride ophthalmic solution 0.4%) was FDA-approved in 2023 for the treatment of presbyopia in adults. Presbyopia is the age-related loss of near focus that makes reading, texting, and other close-up tasks harder after age 40.
QLOSI contains pilocarpine, a medication that has been used in eye care for decades. The 0.4% concentration in QLOSI is formulated to improve near vision with fewer side effects than higher-concentration pilocarpine products.
Your eye doctor can determine whether QLOSI is appropriate for your situation based on your eye health, prescription, and daily visual needs.
According to the FDA label (2023), QLOSI is a muscarinic cholinergic agonist that reduces pupil size, increasing your eye's depth of focus for near vision without changing the lens structure. A smaller pupil works like a camera aperture, sharpening the focus range so you can read more easily.
The effect is temporary. You apply the drops and your near vision improves for several hours. When the medication wears off, your near vision returns to its previous state.
QLOSI does not reverse or stop the aging process that causes presbyopia. It provides temporary optical improvement each time you use it.
According to the AAO, QLOSI is one of three FDA-approved presbyopia eye drops, alongside pilocarpine 1.25% (approved 2021) and a third option approved between 2021 and 2025. Each product uses pilocarpine at a different concentration with different inactive ingredients.
The 0.4% concentration in QLOSI sits between the lower and higher doses available in competing products. Your eye doctor considers the concentration, dosing schedule, and your tolerance when choosing among them.
None of these drops cure presbyopia or replace reading glasses permanently. They offer an alternative for times when you prefer not to wear glasses for near tasks.
Using QLOSI: Dosing and Application
According to the FDA label (2023), the recommended dose is one drop in each eye once daily. An optional second dose two to three hours later is permitted, with a maximum of twice daily.
Most people apply their first dose in the morning to get near-vision improvement during their most active hours. If you find the effect wears off by afternoon, you can use the optional second dose.
Do not exceed two doses per day. Using more than recommended does not improve the effect and may increase side effects.
Wash your hands before handling the bottle. Tilt your head back, pull down your lower eyelid to create a small pocket, and let one drop fall into each eye without touching the dropper tip to your eye or eyelid.
Close your eyes for one to two minutes after application and press gently on the inner corner near your nose. This reduces drainage into your nasal passages and helps the medication stay in your eye longer.
If you wear contact lenses, remove them before applying QLOSI and wait at least 10 minutes before reinserting them.
Most people notice improved near vision within 15 to 30 minutes of application. The effect can last several hours, though the duration varies from person to person.
Your distance vision may decrease slightly while the drops are active, especially in dim lighting. The smaller pupil lets in less light, which can make dark environments feel darker than usual.
Your eye doctor discusses realistic expectations during your appointment. QLOSI may reduce your dependence on reading glasses for many tasks, but it may not replace them entirely for fine print or prolonged close work.
Side Effects and Safety Information
According to the FDA clinical review (NDA 217836), the most common adverse events in clinical trials of QLOSI were instillation site pain and headache, reported in 5% to 8% of patients. These side effects are usually mild and decrease with continued use.
Some people notice a temporary ache around the brow or forehead after application. This happens because pilocarpine stimulates the ciliary muscle inside the eye, and the sensation fades as the muscle relaxes.
Mild redness or tearing at the time of application is also possible. These reactions are short-lived and do not indicate a serious problem in most cases.
According to the AAO, pilocarpine-based drops can cause haloed or dim vision in low light. The smaller pupil reduces the amount of light reaching your retina, which can make driving at night or moving through dark rooms more difficult.
If you apply QLOSI in the morning, the effect on your pupils may have mostly worn off by nighttime. Your eye doctor can help you time your doses to minimize interference with evening activities.
Use caution when driving at night or in poorly lit environments while the drops are active. If you find the low-light effects bothersome, discuss alternative timing or options with your eye doctor.
According to the AAO, pilocarpine-class presbyopia drops are not appropriate for all patients. You should not use QLOSI if you have certain types of glaucoma (specifically narrow-angle glaucoma) or active inflammation inside the eye (uveitis).
Tell your eye doctor about any history of retinal detachment, retinal tears, or high myopia. Pilocarpine stimulates the ciliary muscle, and in rare cases this can affect the vitreous and retina.
Pregnant or breastfeeding patients should discuss the risks and benefits with their eye doctor before using QLOSI. The safety data in these populations is limited.
QLOSI and Your Overall Vision Care
Reading glasses provide consistent, predictable near correction without side effects. QLOSI offers a glasses-free option for specific situations when you prefer not to wear readers.
Many people use both: QLOSI when they want convenience during active parts of their day, and reading glasses for extended close work like reading a book or crafting. Your eye doctor can recommend the combination that suits your lifestyle.
Cost is another factor. QLOSI is a prescription medication with ongoing costs, while reading glasses are a one-time purchase. Your eye doctor reviews the practical considerations with you.
Presbyopia affects all adults past age 40 and progresses over time. QLOSI addresses the symptom (blurred near vision) but does not stop the underlying aging process in the lens.
As your presbyopia advances, you may need stronger reading glasses or a different management approach. Your eye doctor monitors your near vision at regular exams and adjusts your plan as needed.
Other options for presbyopia include multifocal contact lenses, progressive eyeglasses, and surgical procedures like refractive lens exchange. QLOSI adds another tool to the range of choices available to you.
Your eye doctor schedules a follow-up visit after you start QLOSI to check how well the drops are working and whether you are tolerating them. Bring any questions about timing, side effects, or expectations to this appointment.
If QLOSI does not give you the near-vision improvement you hoped for, your doctor can explore other options. Every patient responds differently to pilocarpine-based drops.
Continue your regular comprehensive eye exams regardless of whether you use QLOSI. Presbyopia drops do not replace routine eye health monitoring.
Questions About QLOSI for Presbyopia
The near-vision improvement from QLOSI lasts several hours for most people. The exact duration depends on your individual response. If the effect fades by early afternoon, the optional second daily dose can extend your near-vision improvement.
Tell your eye doctor about all eye medications you use. If you take glaucoma drops or other prescription eye medications, your doctor advises you on timing and compatibility. Wait at least five minutes between different eye drops.
QLOSI provides the most noticeable benefit for mild to moderate presbyopia. If you have advanced presbyopia requiring strong reading glasses, the drops may not provide enough improvement for tasks like reading fine print. Your eye doctor evaluates your specific level of presbyopia.
The smaller pupil can reduce distance clarity and dim your vision in low light. Most people find the trade-off acceptable during daylight hours. Your eye doctor helps you weigh the near-vision benefit against any distance-vision change.
QLOSI addresses near-vision blur from presbyopia, but you still need a comprehensive eye exam to check for other conditions. If you also have myopia, hyperopia, or astigmatism, you may need glasses or contacts for distance vision even while using QLOSI for near tasks.
Clinical trials evaluated QLOSI over 15 days. Long-term safety data is still limited. Your eye doctor monitors you at follow-up visits and can adjust your treatment if any concerns arise over time.
Ask Your Eye Doctor About QLOSI
Your eye doctor can evaluate whether QLOSI fits your presbyopia management plan and show you how to use it for the best results. Schedule an appointment to discuss your near-vision options.